{"name":"Cavion, Inc.","slug":"cavion-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxPeGFKSEU4ZzlQek9hdDROV08temtJYXNoWGY2cWVtMEFMVEdtRTRZdjlEYXJjaWVLLTM0aDBVMzZlTWdBTHppNWdweXRNQlQyYnktZ3oxSXoyVUJsbzVaYko1Z3NxaUJndzQxTW11cWthT3dmbFZsU3p2eWZydk1yVnRRS080OWRvVWpSZDIwRzhiTEFJd2dVYkJsdzZhcWlrNk5RakNGM05fOGRyTmFhTHFrUXcxTG9lRnV0bk1xRXpEYmFOS3ZfZldUNE1TVFlhNmZ6WEVkZXhXeW8ybzZOUUZ5dDEyeHRoUjZJQ0VveGptMXVHaXhSQnB3bWtVSkRXc0RyUm9rT3ZyWVBmMWNjOUFLMy14NGlTWHdCTDdWNkdTVG9ETTBLa0N5ek9Ob2hRSDJESWc1dS10di1CWXVacWh4bER3VVFDUGhJZmJEMzc?oc=5","date":"2021-12-15","type":"trial","source":"PR Newswire","summary":"Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2b Clinical Trial Evaluating Novel Suvecaltamide (JZP385) for Once-Daily Treatment of Adults with Essential Tremor - PR Newswire","headline":"Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2b Clinical Trial Evaluating Novel Suvecaltamide (JZP385)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQTThvamN2QVgwQThrWk9RQ25RbkZkTWxTTFBSOUlUSFNUQmxYZ0o3bzl0ZlE1MlV3RGFIRVJGQ3BLXzk1ZHVTMlRXSXJVY1h3WVpwdkxyamthZ3FrbFVwUy1lRlFnaHdaazJ5cC1OekFQMjNhSktlY2UydTYtZFQxMTFXdUtpNUVacENpaGdCYjFkMmVELTNuNG03UVo0cHdBckE?oc=5","date":"2019-08-24","type":"deal","source":"C&EN","summary":"Jazz acquires neuroscience company Cavion for $52.5 million - C&EN","headline":"Jazz acquires neuroscience company Cavion for $52.5 million - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE0zTnVYZFNvcVF6OXNVRENpMWlQZXFCUUxESEFBUFlRZXh3UHVIeTJ3dHdiVTF5VVhvSDU4QllRSkNBQXVHZTB0cGJPcUItV1BZTzRBYXNFN2hKT09QNHA1bHhFRmlmQ24teElVWHF2RDlkUQ?oc=5","date":"2017-03-25","type":"pipeline","source":"Charlottesville Tomorrow","summary":"Cavion hopes to grow and inspire with venture capital success - Charlottesville Tomorrow","headline":"Cavion hopes to grow and inspire with venture capital success","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}